Anti-lipid oligoclonal IgM bands contribute to progressive multifocal leukoencephalopathy (PML) risk stratification in multiple sclerosis patients treated with natalizumab
Publication date: | 2013 |
Publisher version: | https://doi.org/10.1177%2F1352458513502433 |
Descripción física: | p. 56-57 |
Description: |
Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (29th, 2013, Copenhagen) |
Identificador local: |
20141123 |
